Gastroduodenal Crohn's disease: medical management

Inflamm Bowel Dis. 2003 Mar;9(2):127-8; discussion 131. doi: 10.1097/00054725-200303000-00008.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Anti-Ulcer Agents / administration & dosage
  • Antibodies, Monoclonal / administration & dosage
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Crohn Disease / pathology
  • Drug Therapy, Combination
  • Duodenitis / complications
  • Duodenitis / drug therapy*
  • Duodenitis / pathology
  • Female
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / pathology
  • Gastritis / complications
  • Gastritis / drug therapy*
  • Gastritis / pathology
  • Gastrointestinal Agents / administration & dosage*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Infliximab
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / pathology
  • Long-Term Care
  • Male
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Anti-Ulcer Agents
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Infliximab